Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology
The Rise And Rise Of Artificial Intelligence
More than 75 industry executives and experts gazed into the crystal ball and shared with Scrip their predictions around transformative technologies. Perhaps unsurprisingly, AI was the dominant theme – but gene editing, cell therapies and new targeting modalities were also among the highlights.
You may also be interested in...
In this week's podcast edition of Five Must-Know Things: the biggest drug launches expected in 2024; Roche’s Pharma CEO talks about growth momentum; 10 pivotal studies to look out for this year; the obesity market now and in future; and what does 2024 hold for transformative technology in biopharma.
The EU’s AI innovation package offers funding, training and bespoke initiatives to support AI start-ups and SMEs. The Artificial Intelligence Office has been introduced as part of the package.
A project to validate a depression severity measurement tool that employs artificial intelligence for use in drug trials is moving forward at FDA. The milestone is a sign of things to come – and of the incremental process for AI adoption by the regulator.